目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 IMPACT OF AI/GENERATIVE AI

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION
2.2.1 INSIGHTS FROM PRIMARY
2.2.2 SEGMENT ASSESSMENT METHODOLOGY
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 LIMITATIONS
2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS BUSINESS
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
5.5 SUPPLY CHAIN ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.8 IMPACT OF AI/GEN AI
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGIES
5.9.2 COMPLEMENTARY TECHNOLOGIES
5.9.3 ADJACENT TECHNOLOGIES
5.10 PATENT ANALYSIS
5.11 KEY CONFERENCES & EVENTS 2025-2026
5.12 REGULATORY LANDSCAPE
5.12.1 REGULATORY SCENARIO
5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES & OTHER ORGANIZATIONS
5.13 PORTER'S FIVE FORCES ANALYSIS
5.13.1 THREAT OF NEW ENTRANTS
5.13.2 THREAT OF SUBSTITUTE
5.13.3 BARGAINING POWER OF SUPPLIERS
5.13.4 BARGAINING POWER OF BUYERS
5.13.5 INTENSITY OF COMPETITION RIVALRY
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN THE BUYING PROCESS
5.14.2 BUYING CRITERIA FOR END USERS
5.15 INVESTMENT AND FUNDING SCENARIO

6 HIGH CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
6.1 INTRODUCTION
6.2 INSTRUMENTS
6.2.1 CELL IMAGING SYSTEMS
6.2.2 CELL DETECTION AND ANALYSIS SYSTEMS
6.2.3 HIGH CONTENT IMAGING PLATFORMS
6.3 CONSUMABLES & ACCESSORIES
6.3.1 REAGENTS & ASSAY KITS
6.3.2 MICROPLATES
6.3.3 OTHER CONSUMABLES & ACCESSORIES
6.4 SOFTWARE
6.5 SERVICES Note 1: Other consumables & accessories segment is inclusive of cell culture accessories, microscopy accessories, and plate sealers. Note 2: The above product & service segmentation is subject to change during research.

7 HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
7.1 INTRODUCTION
7.2 DRUG DISCOVERY AND DEVELOPMENT
7.2.1 TARGET IDENTIFICATION AND VALIDATION
7.2.2 PRIMARY SCREENING AND SECONDARY SCREENING
7.2.3 COMPOUND PROFILING
7.2.4 OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS (IF ANY)
7.2 TOXICOLOGY
7.3 BASIC RESEARCH Note 3: Basic research application segment is inclusive of cancer cell line screening, epigenetics, gene expression analysis, and stem cell research.

8 HIGH CONTENT SCREENING MARKET, BY END USER, 2022-2029 (USD MILLION)
8.1 INTRODUCTION
8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
8.3 ACADEMIC AND GOVERNMENT INSTITUTES
8.4 CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS

9 HIGH CONTENT SCREENING MARKET, BY REGION, 2022-2029 (USD MILLION)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2 US
9.2.3 CANADA
9.3 EUROPE
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2 GERMANY
9.3.3 UK
9.3.4 FRANCE
9.3.5 ITALY
9.3.6 SPAIN
9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2 JAPAN
9.4.3 CHINA
9.4.4 INDIA
9.4.5 SOUTH KOREA
9.4.6 AUSTRALIA
9.4.7 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2 BRAZIL
9.5.3 REST OF LATIN AMERICA
9.6 MIDDLE EAST
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
9.6.2 GCC COUNTRIES 9.6.2.1 UNITED ARAB EMIRATES (UAE) 9.6.2.2 KINGDOM OF SAUDI ARABIA (KSA) 9.6.2.3 REST OF GCC COUNTRIES
12.6.3 REST OF MIDDLE EAST
9.7 AFRICA
9.7.1 MACROECONOMIC OUTLOOK FOR AFRICA

10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY PLAYERS STRATEGIES/ RIGHT TO WIN
10.3 REVENUE SHARE ANALYSIS (TOP 4-5 PLAYERS)
10.4 MARKET SHARE ANALYSIS (TOP 4-5 PLAYERS)
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS
10.5.5.1 COMPANY FOOTPRINT
10.5.5.2 PRODUCT FOOTPRINT
10.5.5.3 SERVICE FOOTPRINT
10.5.5.4 APPLICATION FOOTPRINT
10.5.5.5 REGION FOOTPRINT
10.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
10.6.5.1 DETAILED LIST OF KEY STARTUPS/ SMES
10.6.5.2 COMPETITIVE BENCHMARKING OF KEY STARTUPS/ SMES
10.7 COMPETITIVE SCENARIO
10.7.1 DEALS
10.7.2 OTHER DEVELOPMENTS
10.8 BRAND/ PRODUCT COMPARATIVE ANALYSIS
10.9 VENDOR VALUATION AND FINANCIAL METRICS OF THE RESIDUAL DNA TESTING MARKET

11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 DANAHER CORPORATION
11.1.2 REVVITY
11.1.3 BD
11.1.4 THERMO FISHER SCIENTIFIC INC.
11.1.5 AGILENT TECHNOLOGIES
11.1.6 MERCK KGAA
11.1.7 BIO-RAD LABORATORIES, INC.
11.1.8 NIKON INSTRUMENTS INC.
11.1.9 CARL ZEISS AG
11.1.10 SARTORIUS AG
11.1.11 YOKOGAWA ELECTRIC CORPORATION
11.1.12 TECAN TRADING AG
11.1.13 CORNING INCORPORATED
11.1.14 CHARLES RIVER LABORATORIES
11.2 OTHER PLAYERS
11.2.1 EVIDENT
11.2.2 PROMEGA CORPORATION
11.2.3 CREATIVE BIOLABS
11.2.4 SYSMEX CORPORATION
11.2.5 ENZO LIFE SCIENCES
11.2.6 STRATEDIGM CORPORATION
11.2.7 AKOYA BIOSCIENCES
11.2.8 SPHERE FLUIDICS
11.2.9 CREATIVE BIOSTRUCTURE
11.2.10 CREATIVE BIOARRAY
11.2.11 CELL SIGNALLING TECHNOLOGY
11.2.12 STANDARD BIOTOOLS
11.2.13 ARACELI BIOSCIENCES

12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS